Answers are grounded in this paper and cite their sources.
The study demonstrates improved hydrophobic drug delivery in MCF-7 cells using halloysite-based nanomaterials, suggesting versatile applications in therapy.
Background: Poor water solubility is a major limitation for the therapeutic use of many anticancer drugs. In this study, we report the design and development of two halloysite-based hybrid nanomaterials for the encapsulation and delivery of hydrophobic and positively charged drugs. Methods: A novel multicavity platform was obtained by covalently grafting calix[5]arene macrocycles onto the external surface of halloysite nanotubes (HNTs), combining lumen encapsulation with supramolecular host–guest recognition. PB4, a planar and hydrophobic pyridinium salt with significant antiproliferative activity, was selected as a model compound. Both PB4-loaded HNTs (HNTs/PB4) and calixarene-functionalized HNTs (HNTs-Calix/PB4) were incorporated into Laponite®-based thixotropic hydrogels to obtain injectable and biocompatible systems. Results: The nanomaterials were thoroughly characterized, and their loading efficiency, release behavior, and aqueous dispersibility were evaluated. Antiproliferative tests on MCF-7 cells demonstrated that both hydrogels retained PB4 activity, with distinct release profiles: the pristine HNTs allowed faster drug availability, while calix[5]arene-functionalized systems promoted sustained release. Conclusions: This work introduces the first example of covalently calixarene-functionalized halloysite and presents a versatile drug delivery platform adaptable to different therapeutic contexts and combination strategies.
No takes yet. Share an insight, caveat, or question.
Cinà et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: